Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.

MLA

Yun, Jong Hyuk, et al. “Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.” Nutrients, vol. 16, no. 20, Oct. 2024. EBSCOhost, https://doi.org/10.3390/nu16203468.

APA

Yun, J. H., Song, G. J., Son, M. W., & Lee, M. S. (2024). Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy. Nutrients, 16(20). https://doi.org/10.3390/nu16203468

Chicago

Yun, Jong Hyuk, Geum Jong Song, Myoung Won Son, and Moon Soo Lee. 2024. “Global Leadership Initiative on Malnutrition Criteria and Immunonutritional Status Predict Chemoadherence and Survival in Stage II/III Gastric Cancer Treated with XELOX Chemotherapy.” Nutrients 16 (20). doi:10.3390/nu16203468.